Strong correlation between the complement-mediated antibody-dependent enhancement of HIV-1 infection and plasma viral load.
OBJECTIVE
We have previously demonstrated that complement-mediated antibody-dependent enhancement (C-ADE) of HIV-1 infection correlates with accelerated immunosuppression and disease progression in HIV-1-infected individuals. In the present work the relationship between C-ADE and plasma HIV-1 RNA concentrations was studied to determine the effect of C-ADE on viral replication.


METHODS
Three studies were performed: (a) C-ADE and HIV-1 RNA concentrations were determined in the serum and plasma aliquots taken at the same time from 98 HIV patients, mostly in the advanced stage of the disease; (b) the above two parameters as well as HIV enzyme-linked immunosorbent assay (ELISA)-reactive antibodies (Abbott HIV 1/2 test), and p24 antigen levels (Abbott antigen test; Abbott, Delkenheim, Germany) were determined in four seroconversion panels purchased from the Boston Biomedica firm; (c) changes of HIV-1 RNA concentration and C-ADE during a 17 month follow-up period were determined in 18 HIV-infected patients. C-ADE was measured by the method previously established in our laboratories. The results were expressed by an enhancement/neutralization index (E/NI). HIV-1 RNA levels were determined with the Amplicor monitor kit (Roche, Basel, Switzerland), and in some experiments with the nucleic acid sequence based amplification (Organon Teknika, Turnhout, Belgium) kits.


RESULTS
(a) We found a highly significant (P<0.0001) positive correlation between E/NI values reflecting the extent of HIV-1 infection enhancement and plasma HIV-1 RNA levels. Both E/NI and HIV-1 RNA levels negatively correlated to the CD4 cell counts. (b) C-ADE was first detected just before, or concomitantly with, seroconversion in 4/4 seroconversion panels. (c) Both E/NI values and HIV-1 RNA levels significantly (P<0.001) increased during a 17 month observation period in 18 HIV-infected patients.


CONCLUSIONS
We found strong association between the extent of the complement-mediated antibody-dependent enhancement of HIV-1 infection and the plasma viral load in HIV patients. On the basis of these findings, C-ADE correlates with HIV replication in vivo, and potentially contributes to the progression of HIV disease.
Szabó
J
J
Institute of Microbiology, University Medical School, Debrecen, Hungary.
Prohászka
Z
Z
Tóth
F D
FD
Gyuris
A
A
Segesdi
J
J
Bánhegyi
D
D
Ujhelyi
E
E
Minárovits
J
J
Füst
G
G
D000293:Adolescent; D000328:Adult; D000368:Aged; D019067:Antibody-Dependent Enhancement / Q000276:immunology*; D002648:Child; D003165:Complement System Proteins / Q000276:immunology*; D005260:Female; D005500:Follow-Up Studies; D015483:HIV Antibodies / Q000276:immunology*; D015658:HIV Infections / Q000097:blood / Q000276:immunology* / Q000503:physiopathology / Q000821:virology; D015497:HIV-1 / Q000235:genetics / Q000254:growth & development*; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D012367:RNA, Viral / Q000097:blood; D014407:Tumor Cells, Cultured; D019562:Viral Load
D015483:HIV Antibodies; D012367:RNA, Viral; D003165:Complement System Proteins